Reduced IFN-alpha secretion by blood dendritic cells in human diabetes.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 16859998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The interferon response circuit: Induction and suppression by pathogenic viruses

  2005cited by this paper
• Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity.

  2005cited by this paper
• Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.

  2005cited by this paper
• Type I interferons (alpha/beta) in immunity and autoimmunity.

  2005cited by this paper
• Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells.

  2005cited by this paper
• Aberrant regulation of interleukin‐12 receptor β2 chain on type 1 cytokine‐stimulated T lymphocytes in type 1 diabetes

  2005cited by this paper
• Evaluating diabetes mellitus as a risk factor for community-acquired infections.

  2005cited by this paper
• Lower expression of Th1‐related cytokines and inducible nitric oxide synthase in mice with streptozotocin‐induced diabetes mellitus infected with Mycobacterium tuberculosis

  2005cited by this paper
• Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity.

  2004cited by this paper
• Poor In Vitro Maturation and Pro‐Inflammatory Cytokine Response of Dendritic Cells in Children at Genetic Risk of Type 1 Diabetes

  2004cited by this paper
• Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.

  2003cited by this paper
• Latent Autoimmune Diabetes in Adults (LADA)

  2003cited by this paper
• Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy

  2003cited by this paper
• Induction of Clinical Autoimmune Disease by Therapeutic Interferon-α

  2003cited by this paper
• Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells.

  2003cited by this paper
• Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study.

  2002cited by this paper
• Ingested Type I Interferon: A Potential Treatment for Autoimmunity

  2002cited by this paper
• Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes.

  2002cited by this paper
• Characterization of monocyte-derived dendritic cells in recent-onset diabetes mellitus type 1.

  2002cited by this paper
• Characterization of human blood dendritic cell subsets.

  2002cited by this paper
• Infections in diabetes.

  2001cited by this paper
• Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity

  2000cited by this paper
• Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization

  2000cited by this paper
• Immunobiology of dendritic cells.

  2000cited by this paper
• Presence of Interleukin 4 or Interleukin 10, but Not Both Cytokines, in Pancreatic Tissue of Two Patients with Recently Diagnosed Diabetes Mellitus Type I

  2000cited by this paper
• Development of Th1-Inducing Capacity in Myeloid Dendritic Cells Requires Environmental Instruction1

  2000cited by this paper
• Stimulatory and inhibitory differentiation of human myeloid dendritic cells.

  2000cited by this paper
• Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: implications for anti‐tumoral cell therapy

  1999cited by this paper
• Human peripheral blood contains two distinct lineages of dendritic cells

  1999cited by this paper
• The nature of the principal type 1 interferon-producing cells in human blood.

  1999cited by this paper
• Constitutive impaired TCR/CD3-mediated activation of T cells in IDDM patients co-exist with normal co-stimulation pathways.

  1999cited by this paper
• Infections in patients with diabetes mellitus.

  1999cited by this paper
• Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes.

  1999cited by this paper
• A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells.

  1999cited by this paper
• Reciprocal control of T helper cell and dendritic cell differentiation.

  1999cited by this paper
• Immune dysfunction in patients with diabetes mellitus (DM).

  1999cited by this paper
• Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines.

  1999cited by this paper
• Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes.

  1998cited by this paper
• Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype.

  1997cited by this paper
• Dominant TCR alpha-chain clonotypes and interferon-gamma are expressed in the pancreas of patients with recent-onset insulin-dependent diabetes mellitus.

  1996cited by this paper
• Defective maturation and function of antigen-presenting cells in type 1 diabetes.

  1995cited by this paper
• Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.

  1995cited by this paper
• Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.

  1995cited by this paper
• Interferon Expression in the Pancreases of Patients With Type I Diabetes

  1995cited by this paper
• Defective T cell receptor/CD3 complex signaling in human type I diabetes

  1994cited by this paper
• Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells.

  1994cited by this paper
• Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature.

  1994cited by this paper
• Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

  1993cited by this paper

• New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic

  2024cites this paper
• Effects of Gut Microbiome Modulation on Reducing Adverse Health Outcomes among Elderly and Diabetes Patients during the COVID-19 Pandemic: A Randomised, Double-Blind, Placebo-Controlled Trial (IMPACT Study)

  2023cites this paper
• Shared genetic architecture between type 2 diabetes and COVID-19 severity

  2022cites this paper
• Association of high SARS-CoV-2 RNAemia with diabetes and mortality in critically ill COVID-19 patients

  2022cites this paper
• The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences

  2022cites this paper
• Geriatric Health Care During the COVID-19 Pandemic: Managing the Health Crisis

  2022cites this paper
• Interleukin-37: A Link Between COVID-19, Diabetes, and the Black Fungus

  2022cites this paper
• Clinical Characteristics and Outcome of COVID-19 among People Living with Diabetes in Nigeria

  2021cites this paper
• Immunometabolic bases of type 2 diabetes in the severity of COVID-19

  2021cites this paper
• Diabetes Induces a Transcriptional Signature in Bone Marrow–Derived CD34+ Hematopoietic Stem Cells Predictive of Their Progeny Dysfunction

  2021cites this paper
• Metformin-induced suppression of IFN-α via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes

  2020cites this paper
• Overexpression of microRNA-216a-3p Accelerates the Inflammatory Response in Cardiomyocytes in Type 2 Diabetes Mellitus by Targeting IFN-α2

  2020cites this paper
• Factors leading to high morbidity and mortality of COVID‐19 in patients with type 2 diabetes

  2020cites this paper
• SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?

  2020cites this paper
• COVID-19 and diabetes mellitus: implications for prognosis and clinical management

  2020cites this paper
• Is the recent increment in attributable deaths to type-2 diabetes (T2D) associated with the latest chikungunya outbreak in a major epidemic area in Brazil?

  2018cites this paper
• Functional status of immune cells in patients with long‐lasting type 2 diabetes mellitus

  2018cites this paper
• Impaired Inflammatory Response to LPS in Type 2 Diabetes Mellitus

  2018cites this paper
• Chikungunya and diabetes, what do we know?

  2018cites this paper
• Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice

  2017cites this paper
• Tim-3 is a Marker of Plasmacytoid Dendritic Cell Dysfunction during HIV Infection and Is Associated with the Recruitment of IRF7 and p85 into Lysosomes and with the Submembrane Displacement of TLR9

  2017cites this paper
• Benefits of flu vaccination for persons with diabetes mellitus: A review.

  2017cites this paper
• Chikungunya Virus Infection and Diabetes Mellitus: A Double Negative Impact

  2016cites this paper
• Reduced interferon‐α production by dendritic cells in type 1 diabetes does not impair immunity to influenza virus

  2015cites this paper
• Enterovirus-Infected β-Cells Induce Distinct Response Patterns in BDCA1+ and BDCA3+ Human Dendritic Cells

  2015cites this paper
• Cell‐based interventions to halt autoimmunity in type 1 diabetes mellitus

  2013cites this paper
• Studies on Antigen-Presenting Cells in Type 1 Diabetes and Crohn's Disease - with Special Emphasis on Dendritic Cells

  2013cites this paper
• Immunobiology of beta-cell destruction.

  2012cites this paper
• Circulating dendritic cell number and intracellular TNF-α production in women with type 2 diabetes

  2012cites this paper
• Negative regulatory responses to metabolically triggered inflammation impair renal epithelial immunity in diabetes mellitus

  2012cites this paper
• Altered Phenotype of Peripheral Blood Dendritic Cells in Pediatric Type 1 Diabetes

  2012cites this paper
• [Cells of innate and adaptive immunity in type 2 diabetes and obesity].

  2012cites this paper
• Increased Levels of Serum Granulocyte-Macrophage Colony-Stimulating Factor Is Associated with Activated Peripheral Dendritic Cells in Type 2 Diabetes Subjects (CURES-99)

  2012cites this paper
• Células de la inmunidad innata y adaptativa en la diabetes mellitus tipo 2 y obesidad

  2012cites this paper
• Autoimmunity and Therapeutic Challenges of Type 1 Diabetes

  2011cites this paper
• Type 1 Diabetic Children and Siblings Share a Decrease in Dendritic Cell and Monocyte Numbers but are Differentiated by Expansion of CD4 + T Cells Expressing IL-17

  2011cites this paper
• Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry

  2010cites this paper
• Immunology of beta-cell destruction.

  2010cites this paper
• Association Between Capacity of Interferon-α Production and Metabolic Parameters

  2010cites this paper
• Altered toll-like receptor signaling pathways in human type 1 diabetes

  2010cites this paper
• Dendritic cell-based therapy in Type 1 diabetes mellitus

  2009cites this paper
• Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 1 diabetes.

  2009cites this paper
• The role of Toll-like receptor pathways in the mechanism of type 1 diabetes.

  2009cites this paper
• Human Cord Blood Stem Cell-Modulated Regulatory T Lymphocytes Reverse the Autoimmune-Caused Type 1 Diabetes in Nonobese Diabetic (NOD) Mice

  2009cites this paper
• Plasmacytoid Dendritic Cells Are Proportionally Expanded at Diagnosis of Type 1 Diabetes and Enhance Islet Autoantigen Presentation to T-Cells Through Immune Complex Capture

  2009cites this paper
• Reduced Frequency of Peripheral Plasmacytoid Dendritic Cells in Type 1 Diabetes

  2008cites this paper
• Innate immunity, insulin resistance and type 2 diabetes.

  2008cites this paper
• Immunomodulation of autoimmune diabetes by dendritic cells

  2008cites this paper
• Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood.

  2008cites this paper
• Reduced frequency of peripheral dendritic cells in type 2 diabetes.

  2008cites this paper
• Differential Contributions of APC Subsets to T Cell Activation in Nonobese Diabetic Mice1

  2008cites this paper
• Innate immunity and its role in type 1 diabetes

  2008cites this paper
• Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus

  2007cites this paper
• Decreased blood dendritic cell counts in type 1 diabetic children.

  2007cites this paper
• The cross-regulatory relationship between human dendritic and regulatory T cells and its role in type 1 diabetes mellitus.

  2007influential citation